PARAMUS, NJ, — Polaryx Therapeutics (“Polaryx” or the “Company”) a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), announced that shares of the Company’s…
Paramus, New Jersey – Checkmarx has announced the acquisition of Tromzo (https://tromzo.com/). According to the company announcement Checkmarx is a global leader in agentic application security, dedicated to providing enterprise-grade protection while simultaneously reducing engineering…
August 28, 2024 08:00 AM Eastern Daylight Time PARAMUS, N.J.–(BUSINESS WIRE)–PsychoGenics, a leader in AI-enabled phenotypic drug discovery, has been awarded a Fast Track Small Business Innovation Research (SBIR) grant by NIMH, worth up to…
According to filings with the U.S. Securities and Exchange Commission, Prompt Therapy Solutions is raising $6,041,870.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Raymond Baliatico played a key…